[ad_1]
The pharmaceutical company AstraZeneca and the University of Oxford suspended testing of a possible vaccine against COVID-19.
Already I was in the final testing phase, but an adverse reaction in a volunteer caused the process to stop.
AstraZeneca has not disclosed any information about the possible side effect, except to call it “a potentially unexplained illness.”
The pharmacist considers it possible that the problem is a coincidence, justifying that diseases of all kinds can arise in studies of thousands of people.
Last week, the European Commission made official the purchase of 300 million doses of this vaccine.
Currently, dozens of them are being developed.
Australia to produce 85 million doses of Oxford / AstraZeneca vaccines
Australia will produce 84.8 million doses of the Oxford University vaccine against the novel coronavirus from 2021 under a multi-million dollar deal, the government announced.
The $ 1.7 billion (€ 1.04 billion) deal will allow Australian company CSL to manufacture a large part of the vaccine developed by the University of Oxford and British pharmaceutical company AstraZeneca. in addition to the vaccines being developed by the University of Queensland, Australia.
The 26 million Australians “will have early access to 3.8 million vaccines at Oxford University in January and February 2021,” the country’s Prime Minister Scott Morrison said in a statement, stressing that vaccines must be safe. and meet health requirements before they are distributed to the population.
Oxford vaccine. The laboratory wants two billion doses on the market as soon as possible
When research results are published in a scientific journal, it is a sign that safe action is being taken on a discovery.
They were this monday The preliminary results of the tests of a vaccine for Covid-19 are known., published in The Lancet.
A The Oxford vaccine was tested in 1,077 volunteers aged 18 to 55. The results are promising, say the researchers, but Portuguese Miguel Castanho, from the Institute of Molecular Medicine, prefers to be more cautious.
“It is good news, but it is the beginning of a long process. And these results do not guarantee the success of a race, which is a marathon, and there is a history of vaccines that failed in later steps. And some almost, almost at the end “, says the Portuguese researcher.
COVID-19. The first doses of the vaccine can arrive in Portugal before 2021
Portugal can receive up to six different vaccines for Covid-19 until the summer of next year.
There is already an agreement signed with the British pharmaceutical AstraZéneca, but the European Union is in negotiations with five other suppliers for the advance purchase of potential vaccines.
At the meeting to analyze the epidemiological situation of covid-19 in Portugal, the president of Infarmed, admitted that the first doses of a vaccine may be available in December this year.
